Sorry...CEO is Paul Fielding not Fleming! Let's just hope Paul...

First 15 Last

Share
Profile

Follow
PortfolioPlus

4,275 Posts.

359

13/03/18

09:24

Post #: 31704700
Share

Originally posted by PortfolioPlus ↑

TFG will be one of those shares where I was right in my assessment of events but totally wrong in the outcome.
I bought in because they looked amateurish and under funded, thus a likely target for much bigger fish like KKR and VTG in an industry which is attracting quite some interest. I still think this will happen but a premium price, for which I was hoping, is out of the question. Right now TFG is in the emergency ward hovering in and out of consciousness. The longer this goes without a resolution, the less we will get.

And in a financial sense I can see why. The 1HFY18 Results - SHOCKING - Comparatives to 1HFY17 should have shown massive improvement - didn't!
Revenue flat - declined by 0.3% despite acquiring a number of businesses during the year
Gross margin (materials, wages, contractors) to sales declined from 30% in 1HFY17 to 20.4% in 1HFT18...50% decline in GP margin!!!
Occupancy Expenses as a % of sales increased from 7.6% to 10.8%
An impairment of $1.55m - which is code for poor acquisition decisions
All up, a loss of $3.399m or 2.7c a share
The Balance Sheet reflects a poor condition - the current ratio is 0.58X. Suppliers will be getting jittery. Cash is down some $1.83m whilst borrowings are up $0.97m...in just the last 6 months!
The MD should not only step down, but retire from the industry, her reputation is shot!
As a shareholder in VTG I hope they can pick this up at a good price and then totally rebrand it. The brand is amateurish and their business model with coolSculpting a total dud!
By about now, Paul Fleming will have to make another convertible note advance or good night nurse and amen!

Expand

Sorry...CEO is Paul Fielding not Fleming! Let's just hope Paul has deep pockets to keep us going until a buyer can be found.

TFG Price at posting: 11.0¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

RCE

Recce scores US$2M deal from US Department of Defense for burn wound infections gel

Week 28 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Bitcoin investors need to know the risks

ARN

Aldoro shares jump 47% on news of strong niobium recoveries from Namibia play